{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:23:21Z","timestamp":1777073001648,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research and Development Directorate of the United Kingdom Department of Health","award":["039\/0031"],"award-info":[{"award-number":["039\/0031"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.12.018","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T09:49:21Z","timestamp":1418377761000},"page":"648-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-2476","authenticated-orcid":false,"given":"Shamez N.","family":"Ladhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Waight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Hallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"England","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly","family":"Burbidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.12.018_bib0005","series-title":"Immunisation against infectious diseases (the green book)","first-page":"235","article-title":"Chapter 12: Meningococcal","author":"Public Health England","year":"2013"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0020","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0025","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1586\/erv.11.142","article-title":"Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules","volume":"10","author":"Borrow","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0035","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0040","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0045","unstructured":"European Centre for Disease Prevention and Control vaccine schedule. 2013. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx [accessed 05.06.14]."},{"key":"10.1016\/j.vaccine.2014.12.018_bib0050","first-page":"1","article-title":"Prevention and control of meningococcal disease","volume":"62","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(90)90264-V","article-title":"An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay","volume":"135","author":"Phipps","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0065","series-title":"ELISA in the clinical microbiology","first-page":"136","article-title":"Diphtheria and tetanus antitoxins","author":"Melville-Smith","year":"1990"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0075","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.vaccine.2005.02.030","article-title":"Immunogenicity and reactogenicity of combined acellular pertussis\/tetanus\/low dose diphtheria vaccines given as a booster to UK teenagers","volume":"23","author":"Southern","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0080","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"Grant","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0085","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0095","series-title":"The immunological basis for immunization series. Module 3: tetanus","author":"Borrow","year":"2007"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0100","series-title":"The immunological basis for immunization series. Module 2: diphtheria","author":"Galazka","year":"1993"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/INF.0b013e31824f34e6","article-title":"Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United Kingdom","volume":"31","author":"Findlow","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clinthera.2011.11.027","article-title":"Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom","volume":"34","author":"Ladhani","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.8.3.265","article-title":"Prevention of meningococcal serogroup C disease by NeisVac-C","volume":"8","author":"Borrow","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/bmj.312.7034.817","article-title":"Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants","volume":"312","author":"Goldblatt","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months","volume":"29","author":"Diez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0135","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0140","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S0950268807009168","article-title":"Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom","volume":"136","author":"McVernon","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.88.5.379","article-title":"Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure","volume":"88","author":"McVernon","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0155","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0160","series-title":"MenC vaccination schedule: planned changes from June 2013","author":"Department of Health and Public Health England","year":"2013"},{"key":"10.1016\/j.vaccine.2014.12.018_bib0165","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2013 advisory committee on immunization practices (ACIP), 2010","volume":"60","author":"Center for Disease Control and Prevention","year":"2011","journal-title":"MMWR Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T21:26:03Z","timestamp":1598563563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14016478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14016478"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}